Document Detail


Synthesis and evaluation of isatin analogs as caspase-3 inhibitors: introduction of a hydrophilic group increases potency in a whole cell assay.
MedLine Citation:
PMID:  21441025     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A series of isatin analogs containing a hydrophilic group, including a pyridine ring, ethylene glycol group, and a triazole ring, have been synthesized, and their inhibition potency for caspase-3 was measured both in vitro (i.e., recombinant enzyme) and in whole cells (HeLa cells). The analogs having a hydrophilic group, including 12, 13, 16, 38, and 40, have dramatically increased activity in vitro and in HeLa cells compared to the corresponding unsubstituted N-phenyl isatin analogs.
Authors:
Wenhua Chu; Justin Rothfuss; Dong Zhou; Robert H Mach
Related Documents :
20664395 - Interpretation of amniotic fluid white blood cell count in "bloody tap" amniocenteses i...
2360565 - Cost containment, quality assurance, and physician microscopy of cerebrospinal fluid wi...
11289205 - A one-tube nested polymerase chain reaction for the detection of mycobacterium bovis in...
3493175 - A new density gradient for the separation of large quantities of rosette-positive and r...
8116475 - Grafting of fast blue labeled glial cells into neonatal rat brain: differential surviva...
7289925 - Hyaluronidase, from wound healing to cancer.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  Bioorganic & medicinal chemistry letters     Volume:  21     ISSN:  1464-3405     ISO Abbreviation:  Bioorg. Med. Chem. Lett.     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-04-04     Completed Date:  2011-07-19     Revised Date:  2014-09-21    
Medline Journal Info:
Nlm Unique ID:  9107377     Medline TA:  Bioorg Med Chem Lett     Country:  England    
Other Details:
Languages:  eng     Pagination:  2192-7     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 Elsevier Ltd. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Caspase 3 / genetics,  metabolism
Caspase Inhibitors*
HeLa Cells
Humans
Hydrophobic and Hydrophilic Interactions
Isatin / analogs & derivatives*,  chemical synthesis,  pharmacology
Protease Inhibitors / chemical synthesis,  chemistry*,  pharmacology
Recombinant Proteins / chemistry,  genetics,  metabolism
Structure-Activity Relationship
Triazoles / chemistry
Grant Support
ID/Acronym/Agency:
CA121952/CA/NCI NIH HHS; HL13851/HL/NHLBI NIH HHS; P01 HL013851/HL/NHLBI NIH HHS; P01 HL013851-42/HL/NHLBI NIH HHS; R21 CA121952/CA/NCI NIH HHS; R21 CA121952-01/CA/NCI NIH HHS; R21 CA121952-02/CA/NCI NIH HHS; R21 CA121952-03/CA/NCI NIH HHS; R21 CA121952-04/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Caspase Inhibitors; 0/Protease Inhibitors; 0/Recombinant Proteins; 0/Triazoles; 82X95S7M06/Isatin; EC 3.4.22.-/Caspase 3
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Discovery of the first non-ATP competitive IGF-1R kinase inhibitors: Advantages in comparison with c...
Next Document:  Synthesis and biological evaluation of 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]-4-ethynylimi...